David A Willard - Concepedia

Author

David A Willard

Institute for Medical Research

Also Known As

DAVID A. WILLARD, DAVID WILLARD, David A Willard, David A. Willard, David Willard

Publications

673

Citations

H-Index

Concepts

All Affiliations

Institute for Medical Research University Medical Center of Princeton Bristol-Myers Squibb (United States)Princeton University

About

David A Willard is an author at Institute for Medical Research specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	346
2	Health Sciences	1	1	13
3	Natural Sciences	1	1	13
4	Public Health	1	1	64
5	Biochemistry	1	1	13

David A Willard

Publications

659

Citations

H-Index

Page 1

	Year	Citations
Disposition of captopril in normal subjects K. J. Kripalani, Doris N. McKinstry, Sampat M. Singhvi, Clinical Pharmacology & Therapeutics	1980	159
Captopril kinetics Kenneth L. Duchin, Sampat M. Singhvi, David A Willard, Clinical Pharmacology & Therapeutics	1982	118
Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia Henry Pan, Arthur R. DeVault, Barbara J Swites, Clinical Pharmacology & Therapeutics Metabolic SyndromeCardiovascular DiseasePharmacologyTotal CholesterolPravastatin Monotherapy	1990	83
Renal handling of captopril: Effect of probenecid Sampat M. Singhvi, Kenneth L. Duchin, David A Willard, Clinical Pharmacology & Therapeutics PharmacotherapyPhysiologically-based Pharmacokinetic ModelingCaptopril LevelsPharmacokineticsRenal Function	1982	72
Effect of Food on the Bioavailability of Captopril in Healthy Subjects Sampat M. Singhvi, Doris N. McKinstry, James M. Shaw, The Journal of Clinical Pharmacology NutritionHealthy SubjectsDietary ExposureGastrointestinal PharmacologyPharmacotherapy	1982	64
Influence of Probenecid and Food on the Bioavailability of Cephradine in Normal Male Subjects Terrence W. Mischler, A. Arthur Sugerman, David A Willard, The Journal of Clinical Pharmacology NutritionMedicinePhysiologyToxicologyIngestion	1974	43
Pharmacokinetics, Safety, and Pharmacologic Effects of Fosinopril Sodium, an Angiotensin‐Converting Enzyme Inhibitor in Healthy Subjects Kenneth L. Duchin, Anothy P. Waclawski, Jan I. Tu, The Journal of Clinical Pharmacology	1991	36
Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia Philip Raskin, Om P. Ganda, Sherwyn Schwartz, The American Journal of Medicine Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineDiabetes	1995	24
Effects of nadolol β-blockade on blood pressure in hypertension Kenneth L. Duchin, Robert A. Vukovich, Leonard G. Dennick, Clinical Pharmacology & Therapeutics HypertensionCardiovascular PharmacologyPharmacotherapyBlood PressureMolecular Pharmacology	1980	17
A Comparative Study of the Effects of Methaqualone and Glutethimide on Sleep in Male Chronic Insomniacs Leonide Goldstein, JOSEPH GRAEDON, David A Willard, The Journal of Clinical Pharmacology and The Journal of New Drugs Sleep DisordersSleepSleep DisorderMedicineNeuropharmacology	1970	17

Page 1